Growth Metrics

Lexicon Pharmaceuticals (LXRX) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.69%
Dec 31, 2025 -38.01%
Sep 30, 2025 -35.87%
Jun 30, 2025 -39.58%
Mar 31, 2025 -28.65%
Dec 31, 2024 30.07%
Sep 30, 2024 16.15%
Jun 30, 2024 17.88%
Mar 31, 2024 156.41%
Dec 31, 2023 18.08%
Sep 30, 2023 44.24%
Jun 30, 2023 181.97%
Mar 31, 2023 19.49%
Dec 31, 2022 41.92%
Sep 30, 2022 11.23%
Jun 30, 2022 -34.57%
Mar 31, 2022 -29.54%
Dec 31, 2021 -32.82%
Sep 30, 2021 -3.69%
Jun 30, 2021 -46.77%
Mar 31, 2021 -47.85%
Dec 31, 2020 -51.21%
Sep 30, 2020 -59.75%
Jun 30, 2020 38.34%
Mar 31, 2020 43.34%
Dec 31, 2019 47.01%
Sep 30, 2019 43.33%
Jun 30, 2019 -29.97%
Mar 31, 2019 -33.17%
Dec 31, 2018 -34.91%
Sep 30, 2018 -5.86%
Jun 30, 2018 -8.41%
Mar 31, 2018 -2.39%
Dec 31, 2017 -8.22%
Sep 30, 2017 -36.26%
Jun 30, 2017 -34.87%
Mar 31, 2017 -35.18%
Dec 31, 2016 -27.05%
Sep 30, 2016 32.16%
Jun 30, 2016 34.18%
Mar 31, 2016 37.48%
Dec 31, 2015 38.31%
Sep 30, 2015 108.58%
Jun 30, 2015 85.65%
Mar 31, 2015 82.55%
Dec 31, 2014 71.93%
Sep 30, 2014 -37.38%
Jun 30, 2014 -30.71%
Mar 31, 2014 -29.85%
Dec 31, 2013 -26.26%
Sep 30, 2013 -16.31%
Jun 30, 2013 -15.13%
Mar 31, 2013 -13.78%
Dec 31, 2012 -13.64%
Sep 30, 2012 21.42%
Jun 30, 2012 20.62%
Dec 31, 2011 17.34%